Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil
BackgroundNeisseria meningitidis serogroup B has been predominant in Brazil, but no broadly effective vaccine is available to prevent endemic meningococcal disease.
Kurt Wollenberg +2 more
exaly +5 more sources
Potential Use of Neisseria meningitidis Serogroup B Vaccines to Prevent Neisseria gonorrhoeae Infection: Epidemiological Considerations. [PDF]
ABSTRACT Introduction Clinical trials are evaluating the efficacy of serogroup B meningococcal (MenB) outer membrane vesicle (OMV) vaccines in preventing gonorrhoea. We assessed the global epidemiology of gonorrhoea and MenB invasive meningococcal disease (IMD) and reviewed national MenB‐OMV vaccination policies to inform potential use of these ...
Gottlieb SL +9 more
europepmc +2 more sources
We have developed a novel Neisseria meningitidis serogroup-specific loop-mediated isothermal amplification (LAMP) assay for six of the most common meningococcal serogroups (A, B, C, W, X, and Y).
Dong Wook Kim +2 more
exaly +3 more sources
Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010-2021. [PDF]
In Italy, Invasive Meningococcal Disease (IMD) due to Neisseria meningitidis serogroup B (MenB) showed the highest incidence rates in infants under one year of age.
Paola Vacca +11 more
doaj +2 more sources
Defining the Efficacy of Meningococcal B Vaccines Against Gonococcal Acquisition: The Current Landscape. [PDF]
ABSTRACT Introduction Gonorrhoea is a major global sexually transmitted infection, with rising incidence and increasing antimicrobial resistance threatening current control strategies. If untreated, Neisseria gonorrhoeae can lead to severe reproductive health sequelae. Gonorrhoea is also linked to increased HIV acquisition and transmission.
Seib KL, Grulich AE.
europepmc +2 more sources
Development of group B meningococcal vaccine: a progress review
Epidemic cerebrospinal meningitis is a respiratory infectious disease caused by Neisseria meningitidis, most commonly manifesting as meningitis and septicaemia.
Wei ZHAO, Shuang BAI, Yan-li KANG
doaj +1 more source
Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis. [PDF]
INTRODUCTION:In sub Saharan Africa, the epidemiology, including the distribution of serogroups of strains of N. meningitidis is poorly investigated in countries outside "the meningitis belt".
Alcides Moniz Munguambe +7 more
doaj +1 more source
Invasive meningococcal disease (IMD) is a devastating disease with significant mortality and long-term morbidity. The COVID-19 pandemic and containment measures have affected the epidemiology of infectious pathogens.
Chen Stein-Zamir +7 more
doaj +1 more source
Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020
New Zealand (Aotearoa) experienced a Neisseria meningitidis serogroup B epidemic during 1991–2006, and incidence remains twice that of other high-income countries. We reviewed clinical, laboratory, and immunization data for children
Cameron Burton +5 more
doaj +1 more source
Artritis por meningococo. Revisión de un caso
N. Meningitidis serogroup (A, B, C), are main causers of disease. Serogroup W-135 incidence is lower nowadays and, although it is increasing, is such an uncommon infection in adults. We report a case of a monoarthritis knee due to Neisseria meningitidis (
Paloma Picallo Lombardia +2 more
doaj +1 more source

